Illinois § 2310-350

§ 2310-350.

Penny Severns Breast, Cervical, and Ovarian Cancer Research Fund. From funds appropriated from the Penny Severns Breast, Cervical, and Ovarian Cancer Research Fund, the Department shall award grants to eligible physicians, hospitals, laboratories, education institutions, and other organizations and persons to enable organizations and persons to conduct research. Disbursements from the Penny Severns Breast, Cervical, and Ovarian Cancer Research Fund for the purpose of ovarian cancer research shall be subject to appropriations. For the purposes of this Section, "research" includes, but is not limited to, expenditures to develop and advance the understanding, techniques, and modalities effective in early detection, prevention, cure, screening, and treatment of breast, cervical, and ovarian cancer and may include clinical trials. Moneys received for the purposes of this Section, including, but not limited to, income tax checkoff receipts and gifts, grants, and awards from private foundations, nonprofit organizations, other governmental entities, and persons shall be deposited into the Penny Severns Breast, Cervical, and Ovarian Cancer Research Fund, which is hereby created as a special fund in the State treasury. Notwithstanding any other provision of law, in addition to any other transfers that may be provided by law, on June 30, 2026, or as soon thereafter as practical, the State Comptroller shall direct and the State Treasurer shall transfer the remaining balance from the Penny Severns Breast, Cervical, and Ovarian Cancer Research Fund into the Carolyn Adams Ticket For The Cure Grant Fund. Upon completion of the transfers, the Penny Severns Breast, Cervical, and Ovarian Cancer Research Fund is dissolved, and any future deposits due to that Fund and any outstanding obligations or liabilities of that Fund pass to the Carolyn Adams Ticket For The Cure Grant Fund. The Department shall create an advisory committee with members from, but not limited to, the Illinois Chapter of the American Cancer Society, Y-Me, the Susan G. Komen Foundation, and the State Board of Health for the purpose of awarding research grants under this Section. Members of the advisory committee shall not be eligible for any financial compensation or reimbursement. The advisory committee is discontinued on June 30, 2026. This Section is repealed on January 1, 2027. (Source: P.A. 104-2, eff. 6-16-25.)